Functional restoration of ventriculo-arterial coupling in cardiogenic shock via dual mechanical support
通过双机械支撑恢复心源性休克心室-动脉耦合的功能
基本信息
- 批准号:10491278
- 负责人:
- 金额:$ 17.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-10 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAdvanced DevelopmentAdvisory CommitteesAffectAnimal ExperimentsAortaAreaBloodBlood VesselsBlood flowCardiacCardiogenic ShockCardiovascular PhysiologyCaringCessation of lifeCharacteristicsChargeCirculationClinicalClinical ResearchClinical SciencesComputer ModelsCouplingCritical CareDevice DesignsDevicesDisease ProgressionDistalEngineeringEquilibriumExtracorporeal Membrane OxygenationFamily suidaeFive-Year PlansGasesHarm ReductionHeartHumanImageImpairmentLeftLeft Ventricular FunctionLeft ventricular structureLifeLinkLiquid substanceLocationMapsMeasurementMechanicsMedicalMentorsMetabolicMethodsModalityModelingMultiple Organ FailureOrganOrgan failureOutcomePatient-Focused OutcomesPatientsPerfusionPhysiciansPhysiologicalPulmonary Heart DiseasePumpRecoveryReportingResearchResearch PersonnelResearch TrainingResidual stateServicesShockShunt DeviceStrokeSystemTechnologyThrombusTimeTitrationsTreesUnited States National Institutes of HealthVelocimetriesVenousVentricularcareerfemoral arteryfunctional restorationheart circulationheart functionheart metabolismhemodynamicsimprovedimproved outcomein silicoinsightinterestmechanical circulatory supportmultimodalityoperationparticleporcine modelpreservationprogramsventricular assist device
项目摘要
PROJECT SUMMARY
Cardiogenic shock is a highly morbid condition - impaired heart function leads to multi-organ failure and death.
Even prompt medical therapy is frequently insufficient and mechanical means of supporting the circulation are
increasingly evolving. Extracorporeal membrane oxygenation (ECMO) has rapidly been embraced to provide
mechanical circulatory support but limited understanding of its impact on left ventricular function restricts its use.
ECMO profoundly disrupts coupling between the left ventricle and the arterial system through introduction of
retrograde perfusion that collides with antegrade blood flow from the failing heart to generate a dynamic
watershed region whose impact on end-organ perfusion and clinical outcomes is unknown.
Recent clinical studies report improved outcomes for ECMO patients when paired with a percutaneous
ventricular assist device (pVAD) to provide for dual mechanical support. Intriguingly this idea mirrors our own
clinical observations in which addition of a pVAD allows for offloading of the left ventricle and improved clinician
control of perfusion. We recently harnessed metrics of interactions between the heart (host) and pVAD (device)
in cardiogenic shock to provide insight into the physiological state of the failing heart and parameters that can
be utilized to track changes in organ function. We have linked pVAD support to ECMO and have discovered that
changes in pVAD operation identify organ recovery or disease progression. We have further investigated the
effects of ECMO on blood flow utilizing computational fluid dynamic modeling to quantify flow disruptions induced
by the introduction of retrograde perfusion.
We hypothesize that dynamic watershed regions affect end-organ perfusion and that pVADs allow for clinician-
controlled modulation of the circulation thereby functionally restoring ventriculo-arterial coupling. We investigate
this hypothesis by: (1) determining ECMO effects on left ventricular function; (2) quantifying vascular flow
dynamics in the ECMO-failing heart circulation; and (3) investigating the effect of dual mechanical support with
ECMO and a pVAD on LV function and vascular flow dynamics. We apply multiscale multimodal methods to
evaluate our hypothesis. We will study the effects of ECMO and then dual mechanical support on LV function in
the intact pig and in studies of patients with cardiogenic shock. We will investigate vascular dynamics utilizing
computational fluid dynamics and benchtop models of the ECMO-failing heart circulation. Our findings will yield
insight into the application and optimization of ECMO support to improve clinical outcomes and device design.
This project makes the most of my clinical interest in shock and mechanical support, engineering background,
and research in multiscale pathophysiologic systems. With the guidance of enlightened mentors and an advisory
committee, I have developed a five-year plan to provide the didactic and research training I need to become a
successful independent investigator focused on the development of advanced mechanical support of end-stage
cardiopulmonary disease.
项目总结
项目成果
期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
COVID-19 patient bridged to recovery with veno-venous extracorporeal membrane oxygenation.
COVID-19 患者通过静脉-静脉体外膜氧合过渡到康复。
- DOI:10.1111/jocs.14829
- 发表时间:2020
- 期刊:
- 影响因子:1.6
- 作者:Rinewalt,Daniel;Coppolino,Anthony;Seethala,Raghu;Sharma,Nirmal;Salim,Ali;Keller,Steve;Mallidi,HariR
- 通讯作者:Mallidi,HariR
Assessing the SAfety and FEasibility of bedside portable low-field brain Magnetic Resonance Imaging in patients on ECMO (SAFE-MRI ECMO study): study protocol and first case series experience.
- DOI:10.1186/s13054-022-03990-6
- 发表时间:2022-04-30
- 期刊:
- 影响因子:15.1
- 作者:Cho, Sung-Min;Wilcox, Christopher;Keller, Steven;Acton, Matthew;Rando, Hannah;Etchill, Eric;Giuliano, Katherine;Bush, Errol L.;Sair, Haris, I;Pitts, John;Kim, Bo Soo;Whitman, Glenn
- 通讯作者:Whitman, Glenn
A Computational Fluid Dynamics Study of the Extracorporeal Membrane Oxygenation-Failing Heart Circulation.
- DOI:10.1097/mat.0000000000001221
- 发表时间:2021-03-01
- 期刊:
- 影响因子:0
- 作者:Nezami FR;Khodaee F;Edelman ER;Keller SP
- 通讯作者:Keller SP
A case series evaluating the effect of esmolol therapy to treat hypoxemia in COVID-19 patients on VV-ECMO.
评估艾司洛尔治疗 VV-ECMO 治疗 COVID-19 患者低氧血症效果的病例系列。
- DOI:10.1177/03913988231176839
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Kim,BoSoo;Keller,StevenP;Dodd-O,JeffreyM
- 通讯作者:Dodd-O,JeffreyM
Transcranial Doppler microemboli and acute brain injury in extracorporeal membrane oxygenation: A prospective observational study.
- DOI:10.1016/j.xjtc.2022.07.026
- 发表时间:2022-10
- 期刊:
- 影响因子:1.6
- 作者:Caturegli, Giorgio;Kapoor, Shrey;Ponomarev, Vladimir;Kim, Bo Soo;Whitman, Glenn J. R.;Ziai, Wendy;Cho, Sung-Min
- 通讯作者:Cho, Sung-Min
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven Paul Keller其他文献
Steven Paul Keller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven Paul Keller', 18)}}的其他基金
Functional restoration of ventriculo-arterial coupling in cardiogenic shock via dual mechanical support
通过双机械支撑恢复心源性休克心室-动脉耦合的功能
- 批准号:
9761563 - 财政年份:2018
- 资助金额:
$ 17.06万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 17.06万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 17.06万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 17.06万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 17.06万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 17.06万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 17.06万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 17.06万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 17.06万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 17.06万 - 项目类别:














{{item.name}}会员




